• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Warfarin Adherence and Its Associated Factors in Thai Older Adults with Atrial Fibrillation.泰国老年房颤患者的华法林依从性及其相关因素
J Multidiscip Healthc. 2024 Sep 14;17:4455-4464. doi: 10.2147/JMDH.S472597. eCollection 2024.
2
Anticoagulation adherence and its associated factors in patients with atrial fibrillation: a cross-sectional study.房颤患者的抗凝依从性及其相关因素:一项横断面研究。
BMJ Open. 2019 Sep 3;9(9):e029974. doi: 10.1136/bmjopen-2019-029974.
3
Association Between Warfarin Control Metrics and Atrial Fibrillation Outcomes in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation.在 Outcomes Registry for Better Informed Treatment of Atrial Fibrillation 中,华法林控制指标与心房颤动结局的关系。
JAMA Cardiol. 2019 Aug 1;4(8):756-764. doi: 10.1001/jamacardio.2019.1960.
4
Warfarin Management and Outcomes in Patients with Nonvalvular Atrial Fibrillation Within an Integrated Health Care System.在综合医疗保健系统中,非瓣膜性心房颤动患者的华法林管理和结局。
J Manag Care Spec Pharm. 2017 Jun;23(6):700-712. doi: 10.18553/jmcp.2017.23.6.700.
5
Latent Classes of Adherence to Oral Anticoagulation Therapy Among Patients With a New Diagnosis of Atrial Fibrillation.新诊断心房颤动患者口服抗凝治疗依从性的潜在类别。
JAMA Netw Open. 2020 Feb 5;3(2):e1921357. doi: 10.1001/jamanetworkopen.2019.21357.
6
Adherence to treatment guidelines: the association between stroke risk stratified comparing CHADS and CHADS-VASc score levels and warfarin prescription for adult patients with atrial fibrillation.遵循治疗指南:比较CHADS和CHADS-VASc评分水平对成人房颤患者进行卒中风险分层与华法林处方之间的关联。
BMC Health Serv Res. 2017 Feb 11;17(1):127. doi: 10.1186/s12913-017-2025-6.
7
Discontinuation/Interruption of Warfarin Therapy in Patients with Nonvalvular Atrial Fibrillation.非瓣膜性心房颤动患者的华法林治疗的停药/中断。
J Manag Care Spec Pharm. 2015 Jul;21(7):596-606. doi: 10.18553/jmcp.2015.21.7.596.
8
International normalized ratio stabilization in newly initiated warfarin patients with nonvalvular atrial fibrillation.非瓣膜性心房颤动初治华法林患者的国际标准化比值稳定情况
Curr Med Res Opin. 2014 Dec;30(12):2437-42. doi: 10.1185/03007995.2014.957822. Epub 2014 Sep 2.
9
Attainment of Target in Therapeutic Range of International Normalized Ratio and Correlates Among Patients on Warfarin Therapy at Jimma Medical Center, Jimma, Ethiopia.在埃塞俄比亚吉姆马医疗中心接受华法林治疗的患者中,国际标准化比值治疗目标的达成及其相关因素。
Clin Ther. 2024 Apr;46(4):354-359. doi: 10.1016/j.clinthera.2024.01.010. Epub 2024 Feb 29.
10
Development of a conceptual model of adherence to oral anticoagulants to reduce risk of stroke in patients with atrial fibrillation.开发一种口服抗凝剂依从性概念模型,以降低心房颤动患者的中风风险。
J Manag Care Pharm. 2012 Jun;18(5):351-62. doi: 10.18553/jmcp.2012.18.5.351.

引用本文的文献

1
The burden of atrial fibrillation and unmet needs of its management in Southeast Asia and South Asia.东南亚和南亚地区心房颤动的负担及其管理方面未满足的需求。
Lancet Reg Health Southeast Asia. 2025 Feb 21;34:100549. doi: 10.1016/j.lansea.2025.100549. eCollection 2025 Mar.

本文引用的文献

1
Exploring the Link between Anticoagulation, Cognitive Impairment and Dementia in Atrial Fibrillation: A Systematic Review.探索心房颤动中抗凝、认知障碍与痴呆之间的联系:一项系统综述。
J Clin Med. 2024 Apr 21;13(8):2418. doi: 10.3390/jcm13082418.
2
Safety and efficacy of non-vitamin K antagonist oral anticoagulants compared with well-controlled warfarin in Thai patients with atrial fibrillation.非维生素K拮抗剂口服抗凝剂与华法林良好控制组相比在泰国房颤患者中的安全性和有效性
Asian Biomed (Res Rev News). 2022 Jun 30;16(3):131-136. doi: 10.2478/abm-2022-0016. eCollection 2022 Jun.
3
Anticoagulants and Dementia: A Systematic Review.抗凝剂与痴呆症:一项系统综述
Cureus. 2023 May 30;15(5):e39693. doi: 10.7759/cureus.39693. eCollection 2023 May.
4
Atrial fibrillation and coronary artery disease: An integrative review focusing on therapeutic implications of this relationship.心房颤动与冠状动脉疾病:一项聚焦于这种关系治疗意义的综合综述。
World J Cardiol. 2023 May 26;15(5):229-243. doi: 10.4330/wjc.v15.i5.229.
5
Comparison of medication adherence to different oral anticoagulants: population-based cohort study.不同口服抗凝药物的用药依从性比较:基于人群的队列研究。
BMJ Open. 2023 Jan 5;13(1):e065700. doi: 10.1136/bmjopen-2022-065700.
6
The prevalence of eHealth literacy and its relationship with perceived health status and psychological distress during Covid-19: a cross-sectional study of older adults in Blekinge, Sweden.在新冠疫情期间,电子健康素养的流行情况及其与感知健康状况和心理困扰的关系:瑞典布莱金厄省老年人的横断面研究。
BMC Geriatr. 2023 Jan 4;23(1):5. doi: 10.1186/s12877-022-03723-y.
7
Predictors of dementia amongst newly diagnosed non-valvular atrial fibrillation patients.新发非瓣膜性心房颤动患者痴呆的预测因素。
Indian Heart J. 2022 Nov-Dec;74(6):505-509. doi: 10.1016/j.ihj.2022.11.009. Epub 2022 Nov 30.
8
Seniors' eHealth literacy, health and education status and personal health knowledge.老年人的电子健康素养、健康与教育状况以及个人健康知识。
Digit Health. 2022 Mar 27;8:20552076221089803. doi: 10.1177/20552076221089803. eCollection 2022 Jan-Dec.
9
Relationship Between Family Functioning and Medication Adherence in Chinese Patients With Mechanical Heart Valve Replacement: A Moderated Mediation Model.中国机械心脏瓣膜置换患者家庭功能与药物依从性的关系:一个有调节的中介模型
Front Pharmacol. 2022 Feb 22;13:817406. doi: 10.3389/fphar.2022.817406. eCollection 2022.
10
Electronic health literacy and health-related outcomes among older adults: A systematic review.电子健康素养与老年人健康相关结局:系统评价。
Prev Med. 2022 Apr;157:106997. doi: 10.1016/j.ypmed.2022.106997. Epub 2022 Feb 18.

泰国老年房颤患者的华法林依从性及其相关因素

Warfarin Adherence and Its Associated Factors in Thai Older Adults with Atrial Fibrillation.

作者信息

Poungkaew Autchariya, Tankumpuan Thitipong, Riangkam Chontira, Kongwatcharapong Junporn, Daekunthod Tassanee, Sriyayang Khachol, Krittayaphong Rungroj, Koirala Binu

机构信息

Department of Medical Nursing, Faculty of Nursing, Mahidol University, Bangkok, Thailand.

Department of Surgical Nursing, Faculty of Nursing, Mahidol University, Bangkok, Thailand.

出版信息

J Multidiscip Healthc. 2024 Sep 14;17:4455-4464. doi: 10.2147/JMDH.S472597. eCollection 2024.

DOI:10.2147/JMDH.S472597
PMID:39295959
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11409932/
Abstract

INTRODUCTION

Older people mostly found unable to adhere with warfarin treatment guidelines. The health service system is challenged in order to improve medication adherence in older population under limited health resources. The purpose of this study was to explore health systems factors on warfarin adherence in older population, particularly in resources constraint setting.

METHODS

This study was a cross-sectional predictive study that enrolled older people who experienced atrial fibrillation (AF) and treated by warfarin, aged 60 years and over, and followed up at the warfarin clinic.

RESULTS

A total of 197 participants with the mean age of 72.03 years (SD = 8.84) was recruited. Almost of them (85.8%) reported adhered to warfarin prescription. More than a half (60.5%) were able to report their targeted INR. Participants who stayed with the family had 5.54 times (95% CI 1.79-19.33), took regular daily dose warfarin had 5.07 times (95% CI 1.05-24.49), perceived targeted INR had 2.94 times (95% CI 1.04-8.29), and received family support had 1.33 times (95% CI 1.11-1.60) increased odds of warfarin adherence than those who did not. Participants who perceived a barrier to taking medication had 0.93 times decreased odds of warfarin adherence than those who did not (95% CI 0.86-0.99).

CONCLUSION

Healthcare system should encourage family to support the older population with AF in order to increase warfarin adherence. Future research should develop intervention combining family support to promote warfarin adherence.

摘要

引言

大多数老年人无法遵循华法林治疗指南。在卫生资源有限的情况下,卫生服务系统面临着提高老年人群药物依从性的挑战。本研究的目的是探讨卫生系统因素对老年人群华法林依从性的影响,特别是在资源受限的环境中。

方法

本研究为横断面预测性研究,纳入年龄在60岁及以上、患有房颤(AF)且接受华法林治疗并在华法林诊所接受随访的老年人。

结果

共招募了197名参与者,平均年龄为72.03岁(标准差=8.84)。其中几乎所有人(85.8%)报告遵循了华法林处方。超过一半(60.5%)的人能够报告其目标国际标准化比值(INR)。与家人同住的参与者华法林依从性的几率比未与家人同住的参与者高5.54倍(95%置信区间1.79-19.33),每天规律服用华法林的参与者高5.07倍(95%置信区间1.05-24.49),知晓目标INR的参与者高2.94倍(95%置信区间1.04-8.29),获得家庭支持的参与者高1.33倍(95%置信区间1.11-1.60)。认为服药存在障碍的参与者华法林依从性的几率比未这样认为的参与者低0.93倍(95%置信区间0.86-0.99)。

结论

医疗保健系统应鼓励家庭支持患有房颤的老年人,以提高华法林依从性。未来的研究应开发结合家庭支持的干预措施,以促进华法林依从性。